PAPER Gonçalves G, Pereira J
SEARCH RESULTS
330921 RESULTS
PAPER Kouri N, Carlomagno Y, Baker M, Liesinger AM, Caselli RJ, Wszolek ZK, Petrucelli L, Boeve BF, Parisi JE, Josephs KA, Uitti RJ, Ross OA, Graff-Radford NR, DeTure MA, Dickson DW, Rademakers R
Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.
Acta Neuropathol. 2014 Feb;127(2):271-82. PubMed: 24121548PAPER Jeong HR, Jo YN, Jeong JH, Kim HJ, Kim MJ, Heo HJ
Blueberry (Vaccinium virgatum) Leaf Extracts Protect Against Aβ-Induced Cytotoxicity and Cognitive Impairment.
J Med Food. 2013 Nov;16(11):968-76. PubMed: 24117094PAPER Picciano AL, Vaden TD
Complexation between Cu(II) and curcumin in the presence of two different segments of amyloid β
Biophys Chem. 2013 Dec 31;184:62-7. PubMed: 24121531PAPER Zhang X, Tian Y, Li Z, Tian X, Sun H, Liu H, Moore A, Ran C
Design and Synthesis of Curcumin Analogues for in Vivo Fluorescence Imaging and Inhibiting Copper-Induced Cross-Linking of Amyloid Beta Species in Alzheimer's Disease.
J Am Chem Soc. 2013 Oct 25; PubMed: 24116384PAPER Tian M, Zhang X, Wang L, Li Y
Curcumin Induces ABCA1 Expression and Apolipoprotein A-I-Mediated Cholesterol Transmembrane in the Chronic Cerebral Hypoperfusion Aging Rats.
Am J Chin Med. 2013;41(5):1027-42. PubMed: 24117066PAPER Chen CW, Lin WY, Chen KB, Wu YS, Kuo YC, Liu HP, Li CY
Inhalational anesthetic sevoflurane rescues retina function in Alzheimer's disease transgenic Drosophila.
Curr Alzheimer Res. 2013 Nov;10(9):1005-14. PubMed: 24117114PAPER Mullan GM, McEneny J, Fuchs M, McMaster C, Todd S, McGuinness B, Henry M, Passmore AP, Young IS, Johnston JA
Plasma Clusterin Levels and the rs11136000 Genotype in Individuals with Mild Cognitive Impairment and Alzheimer's Disease.
Curr Alzheimer Res. 2013 Nov;10(9):973-8. PubMed: 24117116PAPER Lojkowska W, Witkowski G, Bednarska-Makaruk M, Wehr H, Sienkiewicz-Jarosz H, Graban A, Bochynska A, Wisniewska A, Gugala M, Slawinska K, Sawicka B, Poniatowska R, Ryglewicz D
Correlations Between Cerebellar and Brain Volumes, Cognitive Impairments, ApoE Levels, and APOE Genotypes in Patients with AD and MCI.
Curr Alzheimer Res. 2013 Nov;10(9):964-72. PubMed: 24117117PAPER Khan A, Yavorsky C, Diclemente G, Opler M, Liechti S, Rothman B, Jovic S
Reliability of the Alzheimer's Disease Assessment Scale (ADAS-Cog) in longitudinal Studies.
Curr Alzheimer Res. 2013 Nov;10(9):952-63. PubMed: 24117118PAPER Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, AIBL Research Group
Pupil response biomarkers for early detection and monitoring of Alzheimer's disease.
Curr Alzheimer Res. 2013 Nov;10(9):931-9. PubMed: 24117119PAPER He J, Qiao JP, Zhu S, Xue M, Chen W, Wang X, Tempier A, Huang Q, Kong J, Li XM
Serum β-Amyloid Peptide Levels Spike in the Early Stage of Alzheimer- Like Plaque Pathology in an APP/PS1 Double Transgenic Mouse Model.
Curr Alzheimer Res. 2013 Nov;10(9):979-86. PubMed: 24117120PAPER Despa F, Decarli C
Amylin: what might be its role in Alzheimer's disease and how could this affect therapy?
Expert Rev Proteomics. 2013 Oct;10(5):403-5. PubMed: 24117198PAPER Kosaraju J, Murthy V, Khatwal RB, Dubala A, Chinni S, Muthureddy Nataraj SK, Basavan D
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease.
J Pharm Pharmacol. 2013 Dec;65(12):1773-84. PubMed: 24117480PAPER Parekh KD, Dash RP, Pandya AN, Vasu KK, Nivsarkar M
Implication of novel bis-imidazopyridines for management of Alzheimer's disease and establishment of its role on protein phosphatase 2A activity in brain.
J Pharm Pharmacol. 2013 Dec;65(12):1785-95. PubMed: 24117507Current Filters
No filters selected